Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 197.72 Million USD | 11.07% |
| 2022 | 178.01 Million USD | 35.61% |
| 2021 | 131.27 Million USD | 33.14% |
| 2020 | 98.6 Million USD | -10.55% |
| 2019 | 110.22 Million USD | 17.55% |
| 2018 | 93.77 Million USD | 18.65% |
| 2017 | 79.03 Million USD | 20.23% |
| 2016 | 65.73 Million USD | 11.79% |
| 2015 | 58.8 Million USD | 8.91% |
| 2014 | 53.99 Million USD | 14.54% |
| 2013 | 47.13 Million USD | -2.54% |
| 2012 | 48.36 Million USD | 8.1% |
| 2011 | 44.74 Million USD | 8.3% |
| 2010 | 41.31 Million USD | -0.24% |
| 2009 | 41.41 Million USD | -23.55% |
| 2008 | 54.17 Million USD | -5.24% |
| 2007 | 57.16 Million USD | -22.21% |
| 2006 | 73.49 Million USD | 87.69% |
| 2005 | 39.15 Million USD | 19.38% |
| 2004 | 32.79 Million USD | 51.8% |
| 2003 | 21.6 Million USD | 27.06% |
| 2002 | 17 Million USD | 72.18% |
| 2001 | 9.87 Million USD | 85.59% |
| 2000 | 5.32 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 40.16 Million USD | -17.68% |
| 2024 Q2 | 28.07 Million USD | -30.12% |
| 2023 FY | 197.72 Million USD | 11.07% |
| 2023 Q3 | 44.38 Million USD | -22.91% |
| 2023 Q1 | 48.49 Million USD | 9.51% |
| 2023 Q2 | 57.58 Million USD | 18.74% |
| 2023 Q4 | 48.79 Million USD | 9.93% |
| 2022 Q4 | 44.28 Million USD | 1.38% |
| 2022 FY | 178.01 Million USD | 35.61% |
| 2022 Q1 | 44.94 Million USD | 11.78% |
| 2022 Q2 | 45.1 Million USD | 0.36% |
| 2022 Q3 | 43.68 Million USD | -3.16% |
| 2021 Q1 | 26.54 Million USD | -0.29% |
| 2021 FY | 131.27 Million USD | 33.14% |
| 2021 Q3 | 32.79 Million USD | 3.4% |
| 2021 Q4 | 40.21 Million USD | 22.6% |
| 2021 Q2 | 31.72 Million USD | 19.5% |
| 2020 FY | 98.6 Million USD | -10.55% |
| 2020 Q1 | 26.46 Million USD | -13.85% |
| 2020 Q2 | 22.55 Million USD | -14.77% |
| 2020 Q4 | 26.62 Million USD | 15.97% |
| 2020 Q3 | 22.95 Million USD | 1.78% |
| 2019 Q2 | 25.53 Million USD | 0.78% |
| 2019 Q1 | 25.33 Million USD | 4.36% |
| 2019 Q4 | 30.71 Million USD | 7.25% |
| 2019 Q3 | 28.64 Million USD | 12.18% |
| 2019 FY | 110.22 Million USD | 17.55% |
| 2018 Q3 | 22.88 Million USD | -6.72% |
| 2018 Q1 | 22.08 Million USD | -3.1% |
| 2018 Q2 | 24.53 Million USD | 11.09% |
| 2018 FY | 93.77 Million USD | 18.65% |
| 2018 Q4 | 24.27 Million USD | 6.09% |
| 2017 Q2 | 19.31 Million USD | 14.07% |
| 2017 Q4 | 22.79 Million USD | 13.98% |
| 2017 Q3 | 19.99 Million USD | 3.51% |
| 2017 FY | 79.03 Million USD | 20.23% |
| 2017 Q1 | 16.93 Million USD | -3.06% |
| 2016 Q1 | 14.64 Million USD | -7.89% |
| 2016 Q2 | 17.42 Million USD | 18.96% |
| 2016 Q4 | 17.46 Million USD | 7.8% |
| 2016 Q3 | 16.2 Million USD | -6.99% |
| 2016 FY | 65.73 Million USD | 11.79% |
| 2015 Q4 | 15.9 Million USD | 9.84% |
| 2015 FY | 58.8 Million USD | 8.91% |
| 2015 Q3 | 14.47 Million USD | -2.25% |
| 2015 Q2 | 14.8 Million USD | 8.71% |
| 2015 Q1 | 13.62 Million USD | -11.62% |
| 2014 Q1 | 12.53 Million USD | -6.26% |
| 2014 Q2 | 12.71 Million USD | 1.37% |
| 2014 Q3 | 13.33 Million USD | 4.87% |
| 2014 Q4 | 15.41 Million USD | 15.62% |
| 2014 FY | 53.99 Million USD | 14.54% |
| 2013 Q1 | 10.86 Million USD | -6.93% |
| 2013 FY | 47.13 Million USD | -2.54% |
| 2013 Q4 | 13.37 Million USD | 19.93% |
| 2013 Q3 | 11.15 Million USD | -5.0% |
| 2013 Q2 | 11.74 Million USD | 8.05% |
| 2012 Q3 | 11.7 Million USD | -1.12% |
| 2012 FY | 48.36 Million USD | 8.1% |
| 2012 Q1 | 13.14 Million USD | 9.84% |
| 2012 Q2 | 11.83 Million USD | -9.96% |
| 2012 Q4 | 11.67 Million USD | -0.26% |
| 2011 Q3 | 11.08 Million USD | -1.72% |
| 2011 Q2 | 11.28 Million USD | 8.44% |
| 2011 Q1 | 10.4 Million USD | -1.23% |
| 2011 FY | 44.74 Million USD | 8.3% |
| 2011 Q4 | 11.97 Million USD | 7.95% |
| 2010 Q4 | 10.53 Million USD | 5.11% |
| 2010 FY | 41.31 Million USD | -0.24% |
| 2010 Q1 | 10.05 Million USD | 0.06% |
| 2010 Q2 | 10.7 Million USD | 6.41% |
| 2010 Q3 | 10.02 Million USD | -6.35% |
| 2009 Q1 | 11.26 Million USD | 0.37% |
| 2009 Q2 | 11.18 Million USD | -0.75% |
| 2009 Q4 | 10.05 Million USD | 12.72% |
| 2009 Q3 | 8.91 Million USD | -20.26% |
| 2009 FY | 41.41 Million USD | -23.55% |
| 2008 Q1 | 15.07 Million USD | 8.48% |
| 2008 Q3 | 12.48 Million USD | -18.85% |
| 2008 Q4 | 11.22 Million USD | -10.11% |
| 2008 FY | 54.17 Million USD | -5.24% |
| 2008 Q2 | 15.38 Million USD | 2.08% |
| 2007 Q3 | 15.42 Million USD | 10.1% |
| 2007 Q4 | 13.89 Million USD | -9.92% |
| 2007 FY | 57.16 Million USD | -22.21% |
| 2007 Q1 | 13.82 Million USD | 3.37% |
| 2007 Q2 | 14.01 Million USD | 1.34% |
| 2006 Q1 | 14.22 Million USD | 31.12% |
| 2006 Q4 | 13.37 Million USD | -0.09% |
| 2006 Q3 | 13.38 Million USD | -58.8% |
| 2006 Q2 | 32.49 Million USD | 128.39% |
| 2006 FY | 73.49 Million USD | 87.69% |
| 2005 FY | 39.15 Million USD | 19.38% |
| 2005 Q4 | 10.85 Million USD | 14.46% |
| 2005 Q3 | 9.48 Million USD | -0.49% |
| 2005 Q2 | 9.52 Million USD | 2.47% |
| 2005 Q1 | 9.29 Million USD | 1.82% |
| 2004 FY | 32.79 Million USD | 51.8% |
| 2004 Q3 | 8.14 Million USD | 3.15% |
| 2004 Q1 | 7.62 Million USD | 18.41% |
| 2004 Q2 | 7.89 Million USD | 3.5% |
| 2004 Q4 | 9.13 Million USD | 12.12% |
| 2003 Q4 | 6.44 Million USD | 15.88% |
| 2003 Q2 | 5.1 Million USD | 0.0% |
| 2003 FY | 21.6 Million USD | 27.06% |
| 2003 Q3 | 5.55 Million USD | 8.85% |
| 2002 FY | 17 Million USD | 72.18% |
| 2001 FY | 9.87 Million USD | 85.59% |
| 2000 FY | 5.32 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1661.618% |
| Cerus Corporation | 143.15 Million USD | -38.119% |
| OrthoPediatrics Corp. | 137.01 Million USD | -44.304% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1640.395% |
| Talis Biomedical Corporation | 67.18 Million USD | -194.293% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -692.608% |
| Inogen, Inc. | 236.08 Million USD | 16.249% |
| Spectral AI, Inc. | 20.86 Million USD | -847.68% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -253.097% |
| CVRx, Inc. | 76.14 Million USD | -159.678% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -5504.428% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1483.185% |
| Orthofix Medical Inc. | 667.42 Million USD | 70.375% |
| Venus Concept Inc. | 80.47 Million USD | -145.693% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -249.472% |
| Bioventus Inc. | 409.91 Million USD | 51.765% |
| BrainsWay Ltd. | 28.01 Million USD | -605.703% |
| Envoy Medical, Inc. | 17.89 Million USD | -1004.727% |
| electroCore, Inc. | 32.03 Million USD | -517.29% |
| IceCure Medical Ltd | 16.87 Million USD | -1071.628% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -365.979% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -1021.328% |
| MaxCyte, Inc. | 84.84 Million USD | -133.041% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1493.037% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3320.028% |
| PAVmed Inc | 64.82 Million USD | -205.003% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -287.102% |
| RxSight, Inc. | 103.85 Million USD | -90.394% |
| Sight Sciences, Inc. | 126.44 Million USD | -56.367% |
| SI-BONE, Inc. | 156.35 Million USD | -26.462% |
| TELA Bio, Inc. | 84.18 Million USD | -134.863% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -182.237% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 2.774% |
| LivaNova PLC | 843.54 Million USD | 76.56% |
| 908 Devices Inc. | 68.08 Million USD | -190.429% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 59.114% |
| Nemaura Medical Inc. | 7.13 Million USD | -2669.708% |
| NeuroPace, Inc. | 75.29 Million USD | -162.596% |
| LENSAR, Inc. | 33.33 Million USD | -493.125% |
| Apyx Medical Corporation | 51.01 Million USD | -287.557% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -697.885% |
| BioSig Technologies, Inc. | 28.53 Million USD | -593.039% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -3.264% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -448.319% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 76.36% |
| Axonics, Inc. | 270.2 Million USD | 26.824% |
| Outset Medical, Inc. | 198.77 Million USD | 0.526% |
| IRIDEX Corporation | 31.81 Million USD | -521.5% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -9.713% |
| IRadimed Corporation | 30.12 Million USD | -556.393% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -2217.44% |
| INVO Bioscience, Inc. | 7.85 Million USD | -2417.721% |
| Telesis Bio, Inc. | 63.48 Million USD | -211.43% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -100.831% |
| Varex Imaging Corporation | 224.8 Million USD | 12.044% |
| Quipt Home Medical Corp. | 148.66 Million USD | -32.998% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1586.633% |
| Pulmonx Corporation | 112.68 Million USD | -75.463% |
| Dynatronics Corporation | 9.9 Million USD | -1895.594% |
| Modular Medical, Inc. | 17.52 Million USD | -1027.982% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -879.462% |
| Semler Scientific, Inc. | 38.94 Million USD | -407.714% |
| InMode Ltd. | 215.68 Million USD | 8.325% |
| Bruker Corporation | 1.07 Billion USD | 81.631% |
| Cytosorbents Corporation | 48.33 Million USD | -309.054% |
| DexCom, Inc. | 1.69 Billion USD | 88.309% |
| Align Technology, Inc. | 2.07 Billion USD | 90.48% |
| Viveve Medical, Inc. | 22.17 Million USD | -791.733% |
| ZimVie Inc. | 275.12 Million USD | 28.133% |
| Movano Inc. | 29.69 Million USD | -565.962% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -44.039% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3320.028% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -5504.428% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 67.096% |
| Profound Medical Corp. | 33.6 Million USD | -488.409% |
| Insulet Corporation | 939.9 Million USD | 78.963% |
| enVVeno Medical Corporation | 25.23 Million USD | -683.438% |
| Surmodics, Inc. | 98.69 Million USD | -100.334% |
| iCAD, Inc. | 22.22 Million USD | -789.647% |
| Nuwellis, Inc. | 22.61 Million USD | -774.382% |
| Biotricity, Inc. | 17.18 Million USD | -1050.592% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 55.656% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1510.457% |
| InspireMD, Inc. | 22.95 Million USD | -761.542% |
| PAVmed Inc. | 64.82 Million USD | -205.003% |
| BIOLASE, Inc. | 34.66 Million USD | -470.451% |
| Beyond Air, Inc. | 61.7 Million USD | -220.46% |
| FONAR Corporation | 28.6 Million USD | -591.23% |
| AxoGen, Inc. | 149.33 Million USD | -32.402% |
| Vivani Medical, Inc. | 26.96 Million USD | -633.262% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -11.65% |
| Inari Medical, Inc. | 448.59 Million USD | 55.924% |
| UFP Technologies, Inc. | 58.08 Million USD | -240.381% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -3912.583% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -3029.392% |
| Tenon Medical, Inc. | 16.96 Million USD | -1065.276% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2574.476% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -348.325% |
| AdaptHealth Corp. | 1.07 Billion USD | 81.658% |
| Sintx Technologies, Inc. | 15.2 Million USD | -1200.73% |
| NanoVibronix, Inc. | 4.97 Million USD | -3875.95% |
| Quanterix Corporation | 118.1 Million USD | -67.421% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1586.633% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -1269.09% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 49.646% |
| TransMedics Group, Inc. | 182.82 Million USD | -8.152% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -604.522% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1681.468% |
| Hyperfine, Inc. | 52.87 Million USD | -273.967% |
| Establishment Labs Holdings Inc. | 172 Million USD | -14.954% |
| Biomerica, Inc. | 6.97 Million USD | -2733.534% |
| Bone Biologics Corporation | 9.42 Million USD | -1997.132% |
| AVITA Medical, Inc. | 80.77 Million USD | -144.771% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1817.562% |
| Silk Road Medical, Inc | 186.35 Million USD | -6.1% |